Others: Roche, J&J, Sanofi, and AZ have had GLP-1 efforts (some deprioritized) or new dual/triple agonists in development (e.g., Roches pipeline includes a dual agonist announced in 2024)
CJC-1295 and Ipamorelin are growth hormone releasing peptides frequently used together: CJC-1295 boosts the body's own growth hormone levels to aid fat loss and muscle gain, while Ipamorelin stimulates that same growth hormone release and is noted for its minimal side effects
However, Ozempic generally produces greater A1C reduction and more significant weight loss in comparison studies
How your body handles stevia Unlike allulose, stevia isnt absorbed in any meaningful way
Caregivers can play an important role in helping older adults safely and successfully use GLP-1 medications
Lian Z, Wang J, Cao Y, et al